Blood Thinner May Slow Cognitive Decline in Alzheimer’s Patients With AFib
Recent research from Sweden has revealed promising results regarding the use of newer blood thinners, known as non-vitamin K antagonist oral anticoagulants (NOACs), in slowing cognitive decline for individuals suffering from both atrial fibrillation (AFib) and Alzheimer’s disease. The study suggests that these medications not only help decrease the risk of strokes but may also…
